Human KRT10(Keratin 10) ELISA Kit
Human Keratin 10 (KRT10) ELISA Kit |
|||
RD-KRT10-Hu-48Tests | Reddot Biotech | 48 Tests | 600 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
RD-KRT10-Hu-96Tests | Reddot Biotech | 96 Tests | 830.4 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
20-abx152104 | Abbexa |
|
|
Human Keratin 10 (KRT10) ELISA Kit |
|||
abx251545-96tests | Abbexa | 96 tests | 848.4 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
abx574505-96tests | Abbexa | 96 tests | 848.4 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5402.92 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 550.13 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 734.46 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 2945.08 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
4-SEB691Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Keratin 10 (KRT10) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Keratin 10 ELISA Kit (KRT10) |
|||
RK01738 | Abclonal | 96 Tests | 625.2 EUR |
Human Keratin 10(KRT10)ELISA Kit |
|||
QY-E02836 | Qayee Biotechnology | 96T | 433.2 EUR |
Cow Keratin 10 (KRT10) ELISA Kit |
|||
abx519988-96tests | Abbexa | 96 tests | 1093.2 EUR |
Dog Keratin 10 (KRT10) ELISA Kit |
|||
abx519989-96tests | Abbexa | 96 tests | 1093.2 EUR |
Mouse Keratin 10 (KRT10) ELISA Kit |
|||
abx519991-96tests | Abbexa | 96 tests | 801.6 EUR |
Rat Keratin 10 (KRT10) ELISA Kit |
|||
abx519992-96tests | Abbexa | 96 tests | 801.6 EUR |
ELISA kit for Human KRT10 (Keratin 10) |
|||
ELK2149 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Keratin 10 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Keratin 10 (KRT10) Antibody |
|||
20-abx100807 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx100808 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx123052 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx113334 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx013128 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx032944-400ul | Abbexa | 400 ul | 627.6 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx032944-80l | Abbexa | 80 µl | 343.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx032945-400ul | Abbexa | 400 ul | 627.6 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx032945-80l | Abbexa | 80 µl | 343.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx210411 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx332811-100ul | Abbexa | 100 ul | 510 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx329415 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx224350-100ug | Abbexa | 100 ug | 493.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx224458-100ug | Abbexa | 100 ug | 493.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx242429 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx234648-100ug | Abbexa | 100 ug | 610.8 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx211361 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx173242 | Abbexa |
|
|
Recombinant Keratin 10 (KRT10) |
|||
4-RPB691Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Keratin 10 expressed in: E.coli |
|||
Recombinant Keratin 10 (KRT10) |
|||
4-RPB691Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Keratin 10 expressed in: E.coli |
|||
Human Keratin 10 (KRT10) CLIA Kit |
|||
20-abx492996 | Abbexa |
|
|
Human Keratin 10 (KRT10) Protein |
|||
20-abx067604 | Abbexa |
|
|
Rat Keratin 10 (KRT10) Protein |
|||
20-abx067605 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody (Biotin) |
|||
20-abx273364 | Abbexa |
|
|
Keratin 10 (KRT10) Polyclonal Antibody (Human) |
|||
4-PAB691Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10) |
|||
Human KRT10(Keratin, type I cytoskeletal 10) ELISA Kit |
|||
EH2203 | FN Test | 96T | 628.92 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 9.375pg/ml |
|||
Human KRT10/ Keratin, type I cytoskeletal 10 ELISA Kit |
|||
E1399Hu | Sunlong | 1 Kit | 685.2 EUR |
Human Keratin, type I cytoskeletal 10, KRT10 ELISA KIT |
|||
ELI-07330h | Lifescience Market | 96 Tests | 988.8 EUR |
Human Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA4484HU-48T | Shanghai YL Biotech | 48T | 435 EUR |
Human Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA4484HU-96T | Shanghai YL Biotech | 96T | 562.5 EUR |
Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
1-CSB-EP012504HU | Cusabio |
|
|
Description: Recombinant Human Keratin, type I cytoskeletal 10(KRT10) expressed in E.coli |
|||
Human KeRatin, type I cytoskeletal 10 (KRT10) |
|||
1-CSB-YP012504HU1 | Cusabio |
|
|
Description: Recombinant Human KeRatin, type I cytoskeletal 10(KRT10),partial expressed in Yeast |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), APC |
|||
4-PAB691Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with APC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAB691Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with Biotin. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), Cy3 |
|||
4-PAB691Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with Cy3. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), FITC |
|||
4-PAB691Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with FITC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), HRP |
|||
4-PAB691Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with HRP. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), PE |
|||
4-PAB691Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with PE. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat) |
|||
4-PAB691Ra01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10) |
|||
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
KTE61887-48T | Abbkine | 48T | 398.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
KTE61887-5platesof96wells | Abbkine | 5 plates of 96 wells | 2538 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
KTE61887-96T | Abbkine | 96T | 646.8 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human KRT10 (Keratin, Type I Cytoskeletal 10) |
|||
E-EL-H2118 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Human KRT10 (Keratin, Type I Cytoskeletal 10) in samples from Serum, Plasma, Cell supernatant |
|||
Dog KRT10/ Keratin, type I cytoskeletal 10 ELISA Kit |
|||
E0066Do | Sunlong | 1 Kit | 860.4 EUR |
Mouse Keratin, type I cytoskeletal 10, Krt10 ELISA KIT |
|||
ELI-07327m | Lifescience Market | 96 Tests | 1038 EUR |
Bovine Keratin, type I cytoskeletal 10, KRT10 ELISA KIT |
|||
ELI-07328b | Lifescience Market | 96 Tests | 1113.6 EUR |
Rat Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA1722RA-48T | Shanghai YL Biotech | 48T | 465 EUR |
Rat Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA1722RA-96T | Shanghai YL Biotech | 96T | 600 EUR |
Human Keratin, Type I Cytoskeletal 10 (KRT10) CLIA Kit |
|||
abx195422-96tests | Abbexa | 96 tests | 990 EUR |
Keratin 10 antibody |
|||
10-2541 | Fitzgerald | 250 ug | 590.4 EUR |
Description: Mouse monoclonal Keratin 10 antibody |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAB691Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with APC-Cy7. |
|||
Keratin, Type I Cytoskeletal 10 (KRT10) Antibody |
|||
20-abx109953 | Abbexa |
|
|
Keratin 10 (KRT10) Polyclonal Antibody (Rat), APC |
|||
4-PAB691Ra01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with APC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), Biotinylated |
|||
4-PAB691Ra01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with Biotin. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), Cy3 |
|||
4-PAB691Ra01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with Cy3. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), FITC |
|||
4-PAB691Ra01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with FITC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), HRP |
|||
4-PAB691Ra01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with HRP. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), PE |
|||
4-PAB691Ra01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with PE. |
|||
CLIA kit for Human KRT10 (Keratin, Type I Cytoskeletal 10) |
|||
E-CL-H1268 | Elabscience Biotech | 1 plate of 96 wells | 700.8 EUR |
Description: A sandwich CLIA kit for quantitative measurement of Human KRT10 (Keratin, Type I Cytoskeletal 10) in samples from Serum, Plasma, Cell supernatant |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), APC-Cy7 |
|||
4-PAB691Ra01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with APC-Cy7. |
|||
Keratin 10 Cell ELISA Kit |
|||
abx595336-96tests | Abbexa | 96 tests | 764.4 EUR |
Human Keratin- associated protein 10- 10, KRTAP10-10 ELISA KIT |
|||
ELI-19292h | Lifescience Market | 96 Tests | 988.8 EUR |
KRT10 Antibody / Cytokeratin 10 |
|||
V9057-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V9057-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V9057IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V9057SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3188-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3188-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3188SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3310-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3310-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3310SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3603-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
Human KRT10(Keratin 10) ELISA Kit